Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer

NCT00003041 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pyrazoloacridine

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]